Matt TurnerPatient Affordability
Joey CohenMedication Adherence
Brenda SnowAuthentic Patient Voice
Frank BurrellScientific Storytelling
Stacey GandlerBrand Nourishment
Paul TheisenPatient Acquisition
Bud BilanichSuccess Coach
Daniel SontupeMarket Access
Suma Ramadas, PhDMedical Affairs
Pat PurcellMeeting Engagement
David LinetskyPoint-of-Care Marketing
Matthew DurhamOmnidynamic Marketing
Liz KaneImpactful Strategy
Amy GilesIncreasing Engagement
Tasigna is the first and only second-generation tyrosine kinase inhibitor approved in the EU ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email